|
NEW TRENDS IN CLASSIFICATION, MONITORING AND MANAGEMENT OF METABOLIC SYNDROME
Under the Auspices of IFCC
Edited by Prof. Elizabeta Topić, Ph.D. Pika Meško Brguljan Ph.D. Prof. Victor Blaton, Ph.D.
Organizers Croatian Society of Medical Biochemists Slovenian Association for Clinical Chemistry Forum of the European Societies of Clinical Chemistry and Laboratory Medicine Dubrovnik, November 11-12, 2006
Table of contents EDITORIAL 1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Prof. Izet Aganović, MD, Ph.D; Tina Dušek, MD 2. GENETIC SUCCEPTIBILITY TO METABOLIC SYNDROME Prof. Janja Marc, Ph.D. 3. HOW IS THE METABOLIC SYNDROME RELATED TO THE DYSLIPIDEMIA? Prof. Victor Blaton, Ph.D. 4. CORONARY DISEASE AND METABOLIC SYNDROME Prof. Gábor L. Kovács, MD, Ph.D. 5. INSULIN RESISTANCE AND METABOLIC SYNDROME Prof. István Wittmann, MD, Ph.D. 6. PRO-INFLAMMATORY AND PROTHROMBOTIC FACTORS AND METABOLIC SYNDROME Prof. Grazyna Sypniewska, Ph.D. 7. EVIDENCE BASED LABORATORY MEDICINE IN THE DIAGNOSIS OF METABOLIC SYNDROME Prof. Ana Stavljenić Rukavina, Ph.D.; Daria Pašalić, Ph.D. 8. HYPERTENSION AND THE METABOLIC SYNDROME Assist. Prof. Lea Duvnjak, MD, Ph.D. 9. APPROACH TO THE TREATEMENT OF METABOLIC SYNDROME Prof. Izet Aganović,MD, Ph.D.; Tina Dušek, MD
Copyright © 2007 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved.
|